berberine has been researched along with sirolimus in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, SL; Candido, S; Cervello, M; Chappell, WH; Franklin, RA; LaHair, MM; Libra, M; Martelli, AM; McCubrey, JA; Milella, M; Montalto, G; Nicoletti, F; Polesel, J; Steelman, LS; Tafuri, A; Talamini, R | 1 |
| Darzynkiewicz, Z; Halicka, HD; Hsieh, TC; Lee, YS; Li, J; Wu, JM; Zhao, H | 1 |
| Chen, Y; Gao, X; Gou, X; Guo, N; He, X; Hu, Z; Mi, M; Tang, X; Yan, A | 1 |
| Huang, S; Huang, W; Huang, Z; Jia, Z; Lin, L; Zhu, Z | 1 |
| Elkhodairy, KA; Elzoghby, AO; Fang, JY; Helmy, MW; Kabary, DM | 1 |
| Abdelfattah, EA; Elkhodairy, KA; Elzoghby, AO; Fang, JY; Helmy, MW; Kabary, DM | 1 |
| Bao, B; Chen, W; Guo, J; Pan, J; Zhang, D; Zhang, M | 1 |
7 other study(ies) available for berberine and sirolimus
| Article | Year |
|---|---|
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine.
Topics: Acute-Phase Proteins; Antibiotics, Antineoplastic; Benzylamines; Berberine; Biphenyl Compounds; Breast Neoplasms; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; ErbB Receptors; Female; Gene Expression; HT29 Cells; Humans; Lipocalin-2; Lipocalins; MCF-7 Cells; Nitrophenols; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Quinazolines; Sirolimus; Sulfonamides; Tyrphostins | 2012 |
Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling.
Topics: Adaptor Proteins, Signal Transducing; Aspirin; Ataxia Telangiectasia Mutated Proteins; Berberine; Cell Cycle Proteins; Cell Line, Tumor; Cellular Senescence; Cholecalciferol; Deoxyglucose; DNA Damage; DNA-Binding Proteins; Down-Regulation; Enzyme Activation; Flow Cytometry; Histones; Humans; Laser Scanning Cytometry; Membrane Potential, Mitochondrial; Metformin; Mitochondria; Oxidative Stress; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Resveratrol; Ribosomal Protein S6 Kinases; Signal Transduction; Sirolimus; Stilbenes; TOR Serine-Threonine Kinases; Tumor Suppressor Proteins | 2012 |
Berberine sensitizes rapamycin‑mediated human hepatoma cell death in vitro.
Topics: Berberine; Carcinoma, Hepatocellular; Cell Death; Cell Line, Tumor; Drug Synergism; Hep G2 Cells; Humans; Liver Neoplasms; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2014 |
Inhibition of autophagy by berberine enhances the survival of H9C2 myocytes following hypoxia.
Topics: Adenine; AMP-Activated Protein Kinases; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; bcl-2-Associated X Protein; Berberine; Caspase 3; Cell Hypoxia; Cell Line; Cell Survival; Microtubule-Associated Proteins; Myocytes, Cardiac; Pinellia; Rats; Sirolimus | 2017 |
Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma.
Topics: A549 Cells; Animals; Antineoplastic Agents; Berberine; Cell Proliferation; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Humans; Hyaluronic Acid; Lactoferrin; Lipids; Lung Neoplasms; Male; Mice; Nanoparticles; Neoplasms, Experimental; Particle Size; Sirolimus; Surface Properties | 2018 |
Inhalable multi-compartmental phospholipid enveloped lipid core nanocomposites for localized mTOR inhibitor/herbal combined therapy of lung carcinoma.
Topics: A549 Cells; Adenocarcinoma; Administration, Inhalation; Animals; Antineoplastic Combined Chemotherapy Protocols; Berberine; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Humans; Hyaluronic Acid; Hydrophobic and Hydrophilic Interactions; Lactoferrin; Lung Neoplasms; Male; Mice; Nanocomposites; Phospholipids; Sirolimus | 2018 |
Protective effect of berberine against LPS-induced endothelial cell injury via the JNK signaling pathway and autophagic mechanisms.
Topics: Adenine; Anthracenes; Autophagy; Berberine; Cell Proliferation; Cell Survival; Endothelial Cells; Human Umbilical Vein Endothelial Cells; Humans; Lipopolysaccharides; MAP Kinase Signaling System; Protective Agents; Sirolimus | 2021 |